Get started
Author

Asma Essat

Impact of the Timing of Initiation of Antiretroviral Therapy During Primary HIV-1 Infection on the Decay of Cell-Associated HIV-DNA
2015 · Moussa Laanani, Jade Ghosn, et al. · Clinical Infectious Diseases · 131
A highly virulent variant of HIV-1 circulating in the Netherlands
2022 · Chris Wymant, Daniela Bezemer, et al. · Science · 71
Elevated Basal Pre-infection CXCL10 in Plasma and in the Small Intestine after Infection Are Associated with More Rapid HIV/SIV Disease Onset
2016 · Mickaël J. Ploquin, Yoann Madec, et al. · PLoS Pathogens · 57
PDF
TLR7 dosage polymorphism shapes interferogenesis and HIV-1 acute viremia in women
2020 · Pascal Azar, José Enrique Mejía, et al. · JCI Insight · 52
PDF
Spatiotemporal dynamics of HIV-1 transmission in France (1999–2014) and impact of targeted prevention strategies
2017 · on behalf the ANRS PRIMO Cohort Study, Antoine Chaillon, et al. · Retrovirology · 48
PDF
Persistence of monocyte activation under treatment in people followed since acute HIV-1 infection relative to participants at high or low risk of HIV infection
2020 · Sophie Novelli, Camille Lécuroux, et al. · EBioMedicine · 40
PDF
Ultrasensitive Detection of p24 in Plasma Samples from People with Primary and Chronic HIV-1 Infection
2021 · Caroline Passaes, Héloïse M. Delagreverie, et al. · Journal of Virology · 34
PDF
Transient viral exposure drives functionally-coordinated humoral immune responses in HIV-1 post-treatment controllers
2022 · Luis M. Molinos-Albert, Valérie Lorin, et al. · Nature Communications · 29
PDF
Sensitivity to Broadly Neutralizing Antibodies of Recently Transmitted HIV-1 Clade CRF02_AG Viruses with a Focus on Evolution over Time
2018 · Karl Stefic, Mélanie Bouvin-Pley, et al. · Journal of Virology · 27
Long-term Therapeutic Impact of the Timing of Antiretroviral Therapy in Patients Diagnosed With Primary Human Immunodeficiency Virus Type 1 Infection
2017 · Sophie Novelli, Camille Lécuroux, et al. · Clinical Infectious Diseases · 25
PDF
Increasing contribution of integrated forms to total HIV DNA in blood during HIV disease progression from primary infection
2019 · Pauline Trémeaux, Tiphaine Lenfant, et al. · EBioMedicine · 24
PDF
A genetic fingerprint associated with durable HIV remission after interruption of antiretroviral treatment: ANRS VISCONTI/PRIMO
2025 · Asma Essat, Anaïs Chapel, et al. · Med · 17
Nonreactive Human Immunodeficiency Virus Type 1 Rapid Tests After Sustained Viral Suppression Following Antiretroviral Therapy Initiation During Primary Infection
2018 · Karl Stefic, Sophie Novelli, et al. · The Journal of Infectious Diseases · 17
Evolution of the Envelope Glycoprotein of HIV-1 Clade B toward Higher Infectious Properties over the Course of the Epidemic
2018 · Mélanie Bouvin-Pley, Maxime Beretta, et al. · Journal of Virology · 13
Phenotypic properties of envelope glycoproteins of transmitted HIV-1 variants from patients belonging to transmission chains
2018 · Maxime Beretta, Alain Moreau, et al. · AIDS · 13
PDF
Calendar trends in sexual behaviours in a cohort of HIV-infected MSM at the era of treatment as prevention of HIV infection
2018 · Karen Champenois, Rémonie Seng, et al. · AIDS · 12
CXCR3 and CXCR5 are highly expressed in HIV‐1‐specific CD8 central memory T cells from infected patients
2021 · Anaëlle Olivo, Camille Lécuroux, et al. · European Journal of Immunology · 10
PDF
Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trials
2024 · Ilias I. Siempos, Andre C. Kalil, et al. · EClinicalMedicine · 8
PDF
Sexual behaviour and STIs among MSM living with HIV in the PrEP era: the French ANRS PRIMO cohort study
2024 · Virginie Baltes, Paul de Boissieu, et al. · Journal of the International AIDS Society · 7
Common evolutionary features of the envelope glycoprotein of HIV-1 in patients belonging to a transmission chain
2020 · Maxime Beretta, Julie Migraine, et al. · Scientific Reports · 6
PDF
Non-AIDS-Defining Events in Human Immunodeficiency Virus Controllers Versus Antiretroviral Therapy–Controlled Patients: A Cohort Collaboration From the French National Agency for Research on AIDS CO21 (CODEX) and CO06 (PRIMO) Cohorts
2023 · Carmelite Manto, Alicia Castro-Gordon, et al. · Open Forum Infectious Diseases · 5
PDF
The build-up of stock of stable integrated proviruses overtime explains the difficulty in reducing HIV-1 DNA levels when treatment is initiated at the chronic stage of the infection
2023 · Gilbert Mchantaf, Antoine Cheret, et al. · Journal of Virus Eradication · 4
A Genetic Fingerprint Associated with Durable HIV Remission after Interruption of Antiretroviral Treatment. Anrs Visconti
2023 · Asma Essat, Anaïs Chapel, et al. · SSRN Electronic Journal · 3
Immunoblots may not be effective in confirming the recency of HIV-1 infection
2021 · Alice-Andrée Mariaggi, Elise Gardiennet, et al. · Journal of Virological Methods · 3
PDF
Immunovirological status in people with perinatal and adult-acquired HIV-1 infection: a multi-cohort analysis from France
2024 · Rémonie Seng, Pierre Frange, et al. · The Lancet Regional Health - Europe · 2
PDF
Works count: 36
Citation count: 661
H-index: 13
I10-index: 17
Year
Topic
Type